If IGF2 aberrant methylation is merely a surrogate marker for LOI of IGF2, then IGF2 hypermethylation would be expected to be beneficial for maintaining the imprinting status of IGF2 and thus should decrease the risk of developing CRC. This evidence concerns the gene IGF2 and colorectal carcinoma.